NYSE:WAT - Waters Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $199.57 +1.50 (+0.76 %) (As of 11/16/2018 04:00 PM ET)Previous Close$198.07Today's Range$196.96 - $202.1352-Week Range$167.93 - $220.20Volume507,900 shsAverage Volume565,448 shsMarket Capitalization$14.84 billionP/E Ratio26.64Dividend YieldN/ABeta0.94 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts. Receive WAT News and Ratings via Email Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNYSE:WAT Previous Symbol CUSIP94184810 Webwww.waters.com Phone508-478-2000 Debt Debt-to-Equity Ratio0.61 Current Ratio6.63 Quick Ratio5.93 Price-To-Earnings Trailing P/E Ratio26.64 Forward P/E Ratio24.76 P/E Growth2.34 Sales & Book Value Annual Sales$2.31 billion Price / Sales6.55 Cash Flow$9.0920 per share Price / Cash21.95 Book Value$24.77 per share Price / Book8.06 Profitability EPS (Most Recent Fiscal Year)$7.49 Net Income$20.31 million Net Margins2.32% Return on Equity30.68% Return on Assets13.96% Miscellaneous Employees7,000 Outstanding Shares75,750,000Market Cap$14.84 billion OptionableOptionable Waters (NYSE:WAT) Frequently Asked Questions What is Waters' stock symbol? Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT." How will Waters' stock buyback program work? Waters announced that its board has initiated a share repurchase plan on Tuesday, April 24th 2018, which authorizes the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 18.2% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its shares are undervalued. How were Waters' earnings last quarter? Waters Co. (NYSE:WAT) posted its quarterly earnings data on Tuesday, October, 23rd. The medical instruments supplier reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.02. The medical instruments supplier had revenue of $578.02 million for the quarter, compared to analyst estimates of $587.43 million. Waters had a net margin of 2.32% and a return on equity of 30.68%. The business's quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.77 EPS. View Waters' Earnings History. When is Waters' next earnings date? Waters is scheduled to release their next quarterly earnings announcement on Tuesday, January 22nd 2019. View Earnings Estimates for Waters. What guidance has Waters issued on next quarter's earnings? Waters updated its fourth quarter earnings guidance on Tuesday, October, 23rd. The company provided earnings per share (EPS) guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus estimate of $2.69. Waters also updated its FY 2018 guidance to $8.00-8.10 EPS. What price target have analysts set for WAT? 15 equities research analysts have issued 12 month price targets for Waters' shares. Their forecasts range from $185.00 to $230.00. On average, they anticipate Waters' share price to reach $206.0769 in the next year. This suggests a possible upside of 3.3% from the stock's current price. View Analyst Price Targets for Waters. What is the consensus analysts' recommendation for Waters? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters. Has Waters been receiving favorable news coverage? News articles about WAT stock have trended somewhat negative recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an effect on the stock's share price in the next few days. Who are some of Waters' key competitors? Some companies that are related to Waters include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO). Who are Waters' key executives? Waters' management team includes the folowing people: Mr. Christopher James O'Connell, Chairman & CEO (Age 51)Ms. Sherry L. Buck, Sr. VP & CFO (Age 54)Dr. Michael C. Harrington, Sr. VP of Global Markets (Age 57)Mr. Ian S. King, Sr. VP of Global Products (Age 61)Mr. Eugene G. Cassis, Sr. Advisor (Age 61) Who are Waters' major shareholders? Waters' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.41%), Massachusetts Financial Services Co. MA (5.96%), Bank of New York Mellon Corp (6.00%), Baillie Gifford & Co. (3.39%), Janus Henderson Group PLC (2.76%) and Veritas Asset Management LLP (2.14%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters. Which major investors are selling Waters stock? WAT stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Nomura Asset Management Co. Ltd., Massachusetts Financial Services Co. MA, Acadian Asset Management LLC, Smith Asset Management Group LP, Wells Fargo & Company MN, Renaissance Technologies LLC and Mackenzie Financial Corp. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Terrence P Kelly, Thomas P Salice and William J Miller. View Insider Buying and Selling for Waters. Which major investors are buying Waters stock? WAT stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Select Equity Group L.P., Nordea Investment Management AB, Man Group plc, AQR Capital Management LLC, Commonwealth Bank of Australia, Nuance Investments LLC and Jefferies Group LLC. View Insider Buying and Selling for Waters. How do I buy shares of Waters? Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Waters' stock price today? One share of WAT stock can currently be purchased for approximately $199.57. How big of a company is Waters? Waters has a market capitalization of $14.84 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $20.31 million in net income (profit) each year or $7.49 on an earnings per share basis. Waters employs 7,000 workers across the globe. What is Waters' official website? The official website for Waters is http://www.waters.com. How can I contact Waters? Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected] MarketBeat Community Rating for Waters (NYSE WAT)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 342 (Vote Outperform)Underperform Votes: 453 (Vote Underperform)Total Votes: 795MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/17/2018 by MarketBeat.com StaffFeatured Article: What are the benefits of buying treasury bonds?